Tuesday, May 05, 2026

Minor federal fines offer little deterrence to insurers for Medicare Advantage violations, study finds



Using newly obtained federal data, Brown health policy researchers provide one of the clearest looks at how federal regulators impose Medicare Advantage penalties over a 13-year period, and how they fail to.





Brown University





A new study from health policy researchers at the Brown University School of Public Health suggests that while regulators have several tools at their disposal to penalize insurance plans that break the rules, they rely mostly on relatively small financial penalties that may do little to deter violations.

The study, published in JAMA Internal Medicine, raises questions about how effectively federal regulators — primarily the Centers for Medicare & Medicaid Services — are overseeing the fast-growing Medicare Advantage industry and protecting patients, according to researchers from Brown’s Center for Advancing Health Policy through Research.

 “Nobody really knows how this regulatory authority has been imposing its different enforcement tools over the past decade,” said lead study author Zihan Chen, a Brown doctoral student in health services research. “The study was to address this kind of gap and begin to really understand how the federal government is overseeing Medicare Advantage and using its enforcement actions as a tool to punish or deter kinds of violations.”

The data for the study was obtained as through a Freedom of Information Act request and examines enforcement actions against Medicare Advantage insurers from 2010 through 2023 following violations such as inappropriately denying or delaying covered care.

Zihan said the research team was interested in examining CMS oversight because Medicare Advantage, the private alternative to traditional Medicare, now covers more than half of all Medicare beneficiaries in the U.S. and represents a major share of federal health spending. There have also been various formal complaints about Medicare Advantage insurers from beneficiaries, such as aggressive marketing and burdensome prior authorizations.

As the primary regulator, CMS has several enforcement tools, including the ability to terminate contracts, suspend plans from enrolling new members or marketing their products, and issue financial penalties.

The new analysis found that in practice, CMS rarely used its most severe tools and instead relied overwhelmingly on fines. Of 844 enforcement actions identified over the 13-year period, 87% were monetary penalties, while suspensions accounted for about 12%. Contract terminations made up less than 1%.

Even when fines were imposed by CMS, they were relatively small, peaking at about $6.50 per enrollee in 2019. Most other years they were under $3 per enrollee. While these figures could add up to millions of dollars overall, they are still small compared to the thousands of dollars insurers receive per patient each year. The researchers say it appears these amounts do little to change behavior.

“When fines are levied on plans, it almost means nothing compared to the profits the plans are making. This raises questions about meaningful consequences for violations,” said David Meyers, an associate professor of health services, policy and practice at Brown. “It supports a narrative out there that the government is a little bit asleep at the wheel when it comes to actually regulating the program that they have responsibility for.”

The findings also show that enforcement activity is uneven over time, often clustering around CMS audit cycles, suggesting that violations are more likely to be identified during scheduled reviews than during routine monitoring.

Other findings include differences in the types of plans facing enforcement. For example, contracts that were suspended or terminated tended to have lower quality ratings and served higher shares of low-income and minority beneficiaries, raising concerns that disruptions caused by enforcement may disproportionately affect vulnerable populations.

The research team makes clear in the study that enforcement actions by CMS were not rare. About 42% of Medicare Advantage contracts received at least one enforcement action during the study period and about one in five faced multiple actions, mainly the small fines.

Meyers says the reliance on smaller penalties reflects, in part, how CMS has designed its enforcement system.

“They have the authority to do more, but they’re choosing not to,” he said.

Other factors, such as limited resources, legal risks and resistance from insurers, may also shape how aggressively the agency enforces rules, Meyers added.

By assembling more than a decade of records, the new study is one of the first to examine long-term trends in Medicare Advantage enforcement.

“The Medicare Advantage program is so big and so important, but there’s very little enforcement action that seems to be going on to address challenges that have been widely reported,” Meyers said.

 

Biodegradable, all-metal microrobots could transform drug delivery and biopsy procedures



New class of shape-shifting devices combines metal’s strength with safe biodegradability



Digestive Disease Week





CHICAGO, IL (May 5, 2026) — A swarm of tiny, shape-changing, all-metal robots might someday deliver drugs and capture biopsy samples painlessly and then safely dissolve without the need for extraction, according to a study to be presented today at Digestive Disease Week® (DDW) 2026.

These first-of-their-kind microrobots combined durability and safety in testing on mice, said study co-lead author Ling Li, MD, instructor, gastroenterology and hepatology at Johns Hopkins University School of Medicine.

“Existing biodegradable microrobots are made of materials such as polymers or hydrogels that biodegrade, but they lack the strength and rigidity that enable our all-metal microrobots to penetrate and cut tissue, while still leaving no trace behind when their work is done,” Dr. Li said.

Using microrobots may someday replace some conventional, uncomfortable, invasive endoscopy procedures by simply swallowing a capsule. Thousands of the devices packed into a capsule could journey into the body, where, like tiny transformers, the pre-programmed microrobots shift their shapes at their destination to form minuscule grippers to collect tissue samples in areas difficult to reach using traditional methods.

They can also transform into microinjectors to deliver medications, serving as an alternative to injection or intravenous infusion for delivering biologics such as anti-tumor necrosis factor (TNF) agents and glucagon-like peptide-1 (GLP-1) medications. By injecting them under the mucosal lining of the gastrointestinal tract and by targeting particular locations in the body rather than distributing medication broadly, this approach could improve how medications are absorbed. It also could eliminate the need for frequent injections or clinic visits for treatment of gastrointestinal conditions such as inflammatory bowel disease, bleeding and cancer.

By altering the thickness of the metal layers, the research team can control the tension between layers and how they fold to form two-dimensional and three-dimensional shapes.

“The variability of the layers’ thickness and use of other materials determines how long the metals last before they begin to biodegrade,” said co-lead author Wangqu Liu, PhD candidate at Johns Hopkins University Whiting School of Engineering, who designed and fabricated the microrobots. “We can control the degradation rate from minutes to months depending on the application.”

The researchers demonstrated their microrobots’ ability to penetrate the inner lining of the intestine for potential drug delivery in the gastrointestinal tracts of mice. They also showed the devices’ ability to morph as programmed and insert their tips into the layer of tissue just beneath the surface of the intestine without punching holes or causing other damage.

The research team developed a novel liquid-free manufacturing process that enabled them to create a new class of stronger microrobots composed of water-soluble metals and metal oxides, which give them their biodegradable properties. The process uses only a tiny amount of metal.

“It’s typically only a few micrograms, and it’s engineered to stay within established safety limits,” Liu said.

“We see these all-metal, biodegradable devices as an important advancement in the effort to realize the full potential of medical microrobots,” Dr. Li said. “We don’t have to choose between strength and safety. We can have both.”

The researchers acknowledge the Gracias laboratory at the Johns Hopkins University Whiting School of Engineering for microrobot design and fabrication, and the Selaru laboratory at the Division of Gastroenterology and Hepatology of Johns Hopkins School of Medicine for animal testing and clinical applications for this work.

DDW Presentation Details

Dr. Ling Li will present data from the study, “Biodegradable shape-morphing microrobots for safe biopsy or drug delivery in the gastrointestinal system,” abstract Tu2176, at 12:30 p.m. CDT, Tuesday, May 5. For more information about featured studies and a schedule of availability for featured researchers, please visit www.ddw.org/press

###

Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers, and academics in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW is an in-person and online meeting from May 2-5, 2026. The meeting showcases more than 6,000 abstracts and more than 1,000 lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org

 

‘They weren’t burned by accident’: burned stone, child’s bones, and lost jewelry could reveal prehistoric mining camp high in the Pyrenees



Archaeologists uncover possible evidence of ancient copper smelting spanning more than 2,000 years in a mountain cave more than 2,000 meters above sea level





Frontiers

Photo 6 

image: 

Malachite fragments, a mineral rich in copper, recovered during the excavation works at Cova 338. Authorship: Maria D. Guillén / IPHES-CERCA.

view more 

Credit: Maria D. Guillén / IPHES-CERCA.





High in the eastern Pyrenees, archaeologists are revealing the secrets of a prehistoric cave full of hearths containing fragments of green rock that could represent early copper mining. People visited this site for well-planned, well-supplied trips spanning two thousand years, overturning previous assumptions that prehistoric peoples didn’t spend long periods at high altitude. The discovery of a child’s finger bone and baby tooth suggest that, after more excavations, we may find that it was also a burial site.   

“For a long time, high-mountain environments were seen as marginal, places prehistoric communities passed through occasionally,” said Prof Carlos Tornero of the Catalan Institute of Human Paleoecology and Social Evolution, lead author of the article in Frontiers in Environmental Archaeology. “But we found a really rich archaeological sequence, including multiple combustion structures and a very large number of green mineral fragments. We can’t say exactly how long people stayed each time, but the repeated use of the space and the density of remains suggest occupations that were short to medium in duration, but happening again and again over long periods of time.” 

Burning questions 

Cave 338 is found at 2,235m above sea level in the Freser Valley. The scientists excavated an area of 6m2 at its entrance, identifying four layers of occupation. The first, most recent layer was thin, showing the cave was not frequently used at that time, and contained some artefacts from historical periods. The fourth, oldest layer contains only charcoal fragments, dated at 6,000 years old. 

The researchers hit the jackpot in the second and third layers of the excavation: a total of 23 hearths, containing many crushed, burned green mineral fragments. In-depth material analysis to confirm its identity is underway, but the fragments resemble malachite, which can be treated like this to produce copper. Cave 338 looks like an unexpectedly early high-altitude mining camp. 

“Many of these fragments are thermally altered, while other materials in the cave are not, which clearly suggests that fire played an important role in their processing and that there was a deliberate intention behind it,” said Dr Julia Montes-Landa of the University of Granada, co-author. “In other words, they weren’t burned by accident.” 

The hearths cut across each other, indicating that the visitors reused this space frequently, but are still distinct, which suggests that those visits were separated by plenty of time. Radiocarbon dating puts the hearth found in the second layer at about 3,000 years old, while the hearths in the third layer are around 5,500 to 4,000 years old.  

Secrets of the mountains 

The team also found human remains in the third layer — a finger bone and a baby tooth belonging to at least one child, about 11 years old — which could mean there are burials deeper within the cave. However, there isn’t enough evidence to suggest a cause of death or determine if the two bones belonged to the same child. Jewelry found in the second layer offered more information. 

“We recovered two pendants: one made from a shell and another from a brown bear tooth,” said Tornero. “They come from prehistoric contexts, most likely around the second millennium BC. The shell pendant is interesting because it has parallels in other sites in Catalonia, which suggests shared traditions or connections between different communities. The bear tooth pendant is much less common. That might point to something more specific or symbolic, possibly linked to the local environment.” 

Cave 338 wasn’t a full-time home, but the people who came here found their trips valuable enough to keep returning for millennia. The researchers still have a lot of questions about those trips which they hope to answer with future research. For example, further excavation will help us understand more about how and when humans used the cave. They also want to confirm the exact identity of the green mineral and find out where it came from. 

“The identification of the green mineral as malachite is still preliminary,” explained Tornero. “The research ongoing by the University of Granada and the Autonomous University of Barcelona will provide final answers shortly. Also, the excavation hasn’t yet reached the full depth of the site, so the sequence is not completely documented. This summer we will continue the archaeological work.” 

Archaeological excavation works at Cova 338 from the inside. Authorship: IPHES-CERCA.

Detail of the pendant made of Glycymeris sp. recovered during the excavation works at Cova 338. Authorship: IPHES-CERCA.

Pendant made from a bear incisor recovered during the excavation works at Cova 338. Authorship: IPHES-CERCA.

Above 2,000 meters: Cova 338 redefines Pyrenean prehistory



Universitat Autonoma de Barcelona
Above 2,000 meters: Cova 338 redefines Pyrenean prehistory 

image: 

Archaeological excavations in the interior of Cova 338. Authorship: IPHES-CERCA.

view more 

Credit: IPHES-CERCA.





Above 2,000 meters: Cova 338 redefines Pyrenean prehistory

  • The site, located in the Núria Valley, documents recurrent human occupations spanning more than 5,000 years and provides some of the earliest evidence of copper-rich mineral exploitation in Western Europe
     
  • The study, led by the Universitat Autònoma de Barcelona and IPHES-CERCA and published in Frontiers in Environmental Archaeology, challenges the traditional view of high mountain areas as marginal

An international research team led by the Universitat Autònoma de Barcelona (UAB) and the Institut Català de Paleoecologia Humana i Evolució Social (IPHES-CERCA) has documented the highest-altitude prehistoric cave with evidence of intense human occupation known to date in the Pyrenees. The site, known as Cova 338, is located at 2,235 meters above sea level in the Núria Valley (Queralbs, Ripollès - Girona) and currently represents the most significant high-mountain prehistoric site documented in the range.

The results show that the cave was repeatedly occupied between the 5th millennium BCE and the end of the 1st millennium BCE, providing new evidence on the exploitation of high-mountain resources in prehistoric times and challenging the traditional idea that these areas were used only sporadically or marginally. Dating indicates that these occupations occurred in several distinct phases, separated by periods of abandonment, suggesting a planned and recurrent use of this space.

This is the main conclusion of the article published in Frontiers in Environmental Archaeology, led by Carlos Tornero, professor in the Department of Prehistory at the UAB and researcher at IPHES-CERCA, with the participation of researchers from IPHES-CERCA, the Universitat Rovira i Virgili, the University of Granada, the Pompeu Fabra University, and the University of the Balearic Islands, among other institutions.

Intense and organized occupation in a high-mountain environment

For decades, archaeological research has interpreted areas above 2,000 meters in altitude as marginal territories, occupied only occasionally. Cova 338 breaks with this model.

Extensive excavations carried out between 2021 and 2023 have revealed “an exceptional archaeological sequence, including numerous combustion structures, faunal remains, ceramic fragments, and a remarkable assemblage of green minerals, likely malachite, a copper-rich mineral”, explains Carlos Tornero. “For the first time in the Pyrenees, high-mountain prehistoric occupations of significant intensity have been documented, characterized by repeated activities and the direct exploitation of mineral resources within the cave.”

Among the recovered materials are also two pendants: one made from a marine shell (Glycimeris) and another from a brown bear tooth, evidencing personal ornamentation practices. The former has parallels in other Catalan sites, while the latter is much rarer and possibly linked to a specific symbolic meaning.

Cova 338 forces us to rethink the role of high mountain environments in Pyrenean prehistoric societies”, highlights Carlos Tornero. “For a long time, these spaces were assumed to be marginal. What we document here is recurrent occupation, with complex activities and a clear exploitation of mineral resources.”

The evidence suggests that mineral fragments were brought into the cave and subsequently fragmented or processed inside, indicating systematic exploitation of copper-rich minerals in a high-mountain environment throughout the Late Neolithic and the Bronze Age. These data place Cova 338 among the earliest known examples of this type of activity in Western Europe.

Spatial analysis of the site shows a clear internal organization of activities, with differentiated structures and areas. Researchers interpret the cave as a logistical site integrated within well-structured seasonal mobility systems, where human groups returned recurrently to carry out specific tasks.

“The mountain was not a barrier, but an active place within the economic and territorial organization of prehistoric communities”, notes Eudald Carbonell, researcher at IPHES-CERCA and co-author of the study.

A research project under extreme conditions

The research is part of the ARRELS project, a program promoted by the Ministry for Culture of the Government of Catalonia and led by the UAB and IPHES-CERCA, focused on studying the prehistoric roots of human mobility and occupation in the Upper Ripollès region.

Excavations at Cova 338 have posed a major logistical challenge, as access to the cave is only possible on foot from the Núria Valley, with no motorized support allowed. This has required all materials and sediments generated during the digs to be transported manually.

Conducting an archaeological excavation to current scientific standards under these conditions is extraordinarily demanding”, explains Tornero. The work incorporated high-resolution methodologies, including 3D recording of all materials, systematic sediment sampling, and techniques such as washing and flotation, which allow even the smallest remains to be recovered and provide highly detailed information on the activities carried out in the cave.

Given its scientific importance and excellent state of preservation, the site has been protected and access restricted to ensure the conservation of the deposits and facilitate future research.

The work has also been made possible thanks to the logistical and institutional support of the Queralbs Town Council and the Ter and Freser Headwaters Natural Park, which have facilitated fieldwork in this high-mountain environment.

A key reference for European prehistory

Researchers consider Cova 338 to be a key reference for understanding human occupation of the Pyrenean high mountains and the exploitation of their resources during recent prehistory.

This site demonstrates that the Pyrenees were not a marginal territory for prehistoric communities, but a space fully integrated into their mobility strategies and territorial exploitation”, concludes Carlos Tornero.

The results open new lines of research into the role of alpine environments in prehistoric societies and the earliest forms of mineral resource exploitation in high-mountain contexts.

Funding source:This research is funded through the project led by Carlos Tornero and Eudald Carbonell Arrels prehistòriques de la transhumància a l’Alt Ripollès: projecte arqueològic 2022–2025 (code CLT009/22/00060; AGAUR-DGPC, Departament de Cultura, Generalitat de Catalunya) and has had the logistic and institutional support of the Queralbs Town Council and the Ter and Freser Headwaters Natural Park, which have facilitated the development of the excavations in this high mountain environment.

 

Updated alcohol warning labels may prompt people to cut back: Study




Journal of Studies on Alcohol and Drugs
"Government warning" alcohol label 

image: 

"Government warning" alcohol label

view more 

Credit: Journal of Studies on Alcohol and Drugs





by W.B. Kagan

PISCATAWAY, NJ – Although the United States requires a warning label on alcoholic beverages, alcohol-related deaths have risen steadily over the past two decades. However, new labels warning of specific disease risks, including cancer and liver disease, could better motivate reduced drinking, according to a new study in the Journal of Studies on Alcohol and Drugs.

The warning label currently required on alcohol containers in the United States has not changed since its adoption in 1988, despite new evidence linking alcohol to several diseases. The label states the risks of drinking during pregnancy and while driving or operating machinery and warns generally that drinking alcohol “may cause health problems.” The label often goes unnoticed and unremembered by consumers. 

“We wanted to test whether new warnings could better inform consumers about alcohol’s harms and better encourage people to consider cutting back on their drinking,” says lead author Anna H. Grummon, Ph.D., M.S.P.H., assistant professor at the Stanford University School of Medicine. The study was conducted as part of a larger project co-led with Marissa G. Hall, Ph.D., associate professor at the University of North Carolina.

Designed to compare the effects of differently worded and designed warning labels, the study recruited a nationally representative sample of 1,036 adults of legal drinking age (21 and older) who reported drinking at least once a week. 

Participants viewed 10 messages -- one control, eight new warning labels, and the current U.S. warning label -- in random order. They then rated each message on how well it encouraged them to drink less alcohol, reminded them of alcohol’s harms, and informed them of something new. 

“Each participant rated multiple warnings covering a range of health harms -- such as cancer, liver disease, hypertension, and dementia, among others -- so we could make direct, apples-to-apples comparisons between them,” says Grummon. 

All the new alcohol warnings in the study outperformed the current U.S. warning label, but those highlighting cancer risk were particularly effective. This finding is notable as policymakers in the United States and abroad debate whether to adopt a cancer warning on alcohol products. 

“Ireland, for example, is set to require cancer warnings on alcohol containers in the coming years, and Alaska already requires a cancer warning to be posted in bars, restaurants, and liquor stores where alcohol is sold,” says Grummon. “Our findings suggest these policies could help people understand the risks of drinking and potentially reduce consumption.”

Study participants also rated the effectiveness of warning icons and label design. Triangles and octagons were perceived as more effective and attention-grabbing than other icons, such as a magnifying glass.

More research is underway. Grummon and Hall are currently running a randomized trial to test whether new alcohol warnings effectively lead people to drink less. The study will also measure whether the warnings improve knowledge of alcohol-related harms over time.

“We know from tobacco control that well-designed warnings can inform consumers and encourage healthier choices,” says Grummon. “Given that alcohol-related deaths are increasing, we hope policymakers will consider whether updating alcohol warnings should be part of a broader strategy to address alcohol-related harms.”
-----
Grummon, A. H., Lee, C. J. Y., Campos, A. D., Lazard, A. J., Brewer, N. T., Whitesell, C., Ruggles, P. R., Greenfield, T. K., & Hall, M. G. (2026). New alcohol warnings outperform the current U.S. warning in a national survey experiment. Journal of Studies on Alcohol and Drugs, 87(3), 433-443. https://doi.org/10.15288/jsad.25-00226